<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Gut Pathog</journal-id>
<journal-id journal-id-type="iso-abbrev">Gut Pathog</journal-id>
<journal-title-group>
<journal-title>Gut Pathogens</journal-title>
</journal-title-group>
<issn pub-type="epub">1757-4749</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32025243</article-id>
<article-id pub-id-type="pmc">6996179</article-id>
<article-id pub-id-type="publisher-id">346</article-id>
<article-id pub-id-type="doi">10.1186/s13099-020-0346-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut microbiota changes in children with autism spectrum disorder: a systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ho</surname>
<given-names>Lucius Kang Hua</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tong</surname>
<given-names>Valerie Jia Wei</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Syn</surname>
<given-names>Nicholas</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagarajan</surname>
<given-names>Niranjan</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tham</surname>
<given-names>Elizabeth Huiwen</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tay</surname>
<given-names>Stacey K.</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shorey</surname>
<given-names>Shefaly</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tambyah</surname>
<given-names>Paul Anantharajah</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4683-7220</contrib-id>
<name>
<surname>Law</surname>
<given-names>Evelyn Chung Ning</given-names>
</name>
<address>
<email>evelyn_law@nuhs.edu.sg</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>Yong Loo Lin School of Medicine, </institution><institution>National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.418377.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 715X</institution-id><institution>Genome Institute of Singapore (GIS), </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.452264.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0530 269X</institution-id><institution>Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research (A*STAR), </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>Department of Paediatrics, Yong Loo Lin School of Medicine, </institution><institution>National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.410759.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0451 6143</institution-id><institution>Khoo Teck Puat-National University Children’s Medical Institute, National University Health System, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, </institution><institution>National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.410759.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0451 6143</institution-id><institution>Division of Infectious Diseases, </institution><institution>University Medicine Cluster, National University Health System, </institution></institution-wrap>Singapore, Singapore </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>Department of Medicine, Yong Loo Lin School of Medicine, </institution><institution>National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>3</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>12</volume>
<elocation-id>6</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">As more animal studies start to disentangle pathways linking the gut microbial ecosystem and neurobehavioral traits, human studies have grown rapidly. Many have since investigated the bidirectional communication between the gastrointestinal tract and the central nervous system, specifically on the effects of microbial composition on the brain and development.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Our review at the initial stage aimed to evaluate literature on gut microbial alterations in pediatric neurobehavioral conditions. We searched five literature databases (Embase, PubMed, PsychInfo, Scopus, and Medline) and found 4489 published work. As the mechanisms linking gut microbiota to these conditions are divergent, the scope of this review was narrowed to focus on describing gut dysbiosis in children with autism spectrum disorder (ASD).</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">Among the final 26 articles, there was a lack of consistency in the reported gut microbiome changes across ASD studies, except for distinguishable patterns, within limits, for <italic>Prevotella</italic>, Firmicutes at the phylum level, Clostridiales clusters including <italic>Clostridium perfringens</italic>, and <italic>Bifidobacterium</italic> species.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">These results were inadequate to confirm a global microbiome change in children with ASD and causality could not be inferred to explain the etiology of the behaviors associated with ASD. Mechanistic studies are needed to elucidate the specific role of the gut microbiome in the pathogenesis of ASD.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Microbiome</kwd>
<kwd>Microbiota</kwd>
<kwd>Dysbiosis</kwd>
<kwd>Systematic review</kwd>
<kwd>Autism spectrum disorder</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par22">Autism spectrum disorder (ASD) refers to a developmental and neurobehavioral condition characterized by deficits in social communication and social interaction across multiple contexts with restricted, repetitive patterns of behaviour, interests, or activities [<xref ref-type="bibr" rid="CR1">1</xref>]. Recent data suggest that as many as 1 in 59 children are diagnosed with ASD, although other reports not using parental report and school age children generally show a prevalence of 1% globally, with little regional variations in developed countries within North America, Western Europe, Central Latin America, and Asia Pacific [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par23">There is no single known cause for all ASD-related behaviors. Current research alludes to multifactorial etiologies including genetic risk factors, de novo mutations, gene-environment interactions, and environmental factors such as in utero exposures and perinatal events [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Due to reports suggesting that children with ASD have increased prevalence of gastrointestinal symptoms including constipation, diarrhea, and abdominal discomfort, researchers have started to examine the differences in gut microbiome composition in these children [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par24">Longitudinal studies on adults with ASD indicate that 37 to 59% have poor outcomes [<xref ref-type="bibr" rid="CR13">13</xref>]. The average lifetime cost of supporting an individual with ASD is estimated to be at least USD$1.4 million in the United States and £0.92 million in the United Kingdom [<xref ref-type="bibr" rid="CR14">14</xref>]. When a child has concurrent intellectual disability, this cost rises to USD$2.4 million and £1.5 million, respectively [<xref ref-type="bibr" rid="CR14">14</xref>]. While autism-specific behavioral therapies have strong data supporting outcome improvement, there has not been reliable evidence on the effectiveness of environmental modifications including diet, antifungals, fecal microbiota transplants, heavy metal chelation, and vaccine avoidance. The intention of this review is not to discuss potential ways for intervention through gut microbiome modulation. Rather, it is to take a closer look at whether the plethora of literature published provides consistent evidence on features of gut microbiome alterations associated with ASD and to establish the strength of evidence.</p>
<sec id="Sec2">
<title>A new wave of interest in gut microbiome and autism spectrum disorder</title>
<p id="Par25">Human studies have shown that children exposed to maternal inflammation during pregnancy have an increased risk for ASD, yet the mechanisms for this are poorly understood [<xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Since then, promising results from a number of landmark animal studies have revived considerable interest in linkages between ASD and the gut microbiome [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. These animal studies have provided new evidence on mechanisms by which inflammation and gut microbiota influence neurobehaviors. For instance, pregnant mice with intestinal bacteria that induced activation of the maternal immune system, termed maternal immune activation (MIA), produced offspring with impaired sociability and repetitive marble burying behaviours [<xref ref-type="bibr" rid="CR19">19</xref>]. These MIA-associated behaviours were reminiscent of ASD symptoms in humans. Furthermore, cortical patches dominantly localized in the primary somatosensory cortex were affected by MIA and were closely associated with these behavioral abnormalities [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
<p id="Par26">Animal studies have also shown that changes in microbiota lead to changes in behaviors. Raising animals in the absence of microbial colonization, also called gnotobiotic environment, resulted in abnormalities in a variety of complex behaviours. For example, germ-free mice tended to exhibit decreased sociability and less propensity to interact with unfamiliar partners [<xref ref-type="bibr" rid="CR22">22</xref>]. These same mice were found to have abnormalities in brain gene expression, display changes in their hypothalamic–pituitary–adrenal axis, and demonstrate adult hippocampal neurogenesis [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Reintroduction of bacterial strains or restoration of gut microbial ecology in mice resulted in normalization of social behaviours. In one study, treatment with the gut bacterium <italic>Lactobacillus reuteri</italic> (<italic>L. reuteri</italic>) alone sufficiently reversed ASD-like symptoms in mice [<xref ref-type="bibr" rid="CR21">21</xref>]. Alteration of the postnatal gut microbiota by early life treatment with the human gut bacterium <italic>Bacteroides fragilis</italic> (<italic>B. fragilis</italic>) also sufficiently ameliorated deficits in communicative and stereotypic burying behaviour in mice offspring exposed to MIA. A recent study showed that postnatal colonization with human “infant-type” <italic>Bifidobacterium</italic> species showed improved behaviours for gnotobiotic mice [<xref ref-type="bibr" rid="CR24">24</xref>]. Together, these animal studies have hastened interest in human studies comparing gut microbiota between individuals with and without ASD.</p>
</sec>
<sec id="Sec3">
<title>The human gut microbiota</title>
<p id="Par27">The human gut microbiota contains a complex and dynamic population of microorganisms, which are believed to exert a broad effect on the host. Firmicutes and Bacteroidetes are two major microbial phyla in the gut. Both phyla are susceptible to alterations due to factors such as age, genetics, diet, environment, and infection and have roles related to immune dysregulation (e.g. lupus systemic erythematosus), systemic diseases (e.g. metabolic syndrome), and neurological disorders (e.g. Parkinson’s disease) [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
<p id="Par28">The Firmicutes/Bacteroidetes ratio has been shown to change with age, with a ratio of approximately 0.4 in infants and as high as 10.9 in adults [<xref ref-type="bibr" rid="CR26">26</xref>]. Among infants, there is also variability in the relative abundance of Firmicutes and Bacteroidetes. The most recent research demonstrates that clusters of infants with similar abundances of Firmicutes (i.e. the family <italic>Ruminococcaceae</italic>) and Bacteroidetes are associated with distinct cognitive and language profiles [<xref ref-type="bibr" rid="CR27">27</xref>]. Studies on microbiome composition and ASD appear to suggest a trend of increased Firmicutes/Bacteroidetes ratio and reduced <italic>Bacteroides</italic> in the ASD groups compared to controls, leading prior reviews on this topic to support a role for the microbiome as an interface between environmental and genetic risk factors that are associated with ASD [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p id="Par29">However, there has not been a comprehensive review that systematically (1) evaluates the dysbiosis described in children with ASD based on bacterial taxonomy from phylum to species, (2) investigates whether results of dysbiosis are congruous in all cases, and (3) summarises both positive and negative findings down to species in all the studies captured. As such, our review aims to provide a detailed dissection of the current literature on gut microbiota and ASD.</p>
<p id="Par30">To better understand this review, it is important to clarify that Autistic Disorder (AD) and Pervasive Developmental Disorder, not otherwise specified (PDD-NOS) are now both under the umbrella diagnosis of ASD in the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition, better known as DSM-5 (1). Studies published before DSM-5 with the diagnoses of AD and PDD-NOS are reported as ASD severe symptoms (severe) and ASD mild symptoms (mild), respectively, in this review to keep consistent with the current classifications.</p>
</sec>
</sec>
<sec id="Sec4">
<title>Methods</title>
<sec id="Sec5">
<title>Identification of studies</title>
<p id="Par31">A Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram of the study process is provided in Fig. <xref ref-type="fig" rid="Fig1">1</xref>. We conducted a systematic search of five literature databases to identify studies showing gut dysbiosis in neurological disorders. The databases searched were Embase, Medline, PsycINFO, PubMed and Scopus. All databases were searched in three waves, September 2017, August 2018, and April 2019, using the search criteria listed in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1. The collections of papers were reviewed and duplicates were eliminated both electronically and manually. Articles were then screened based on titles and abstracts for eligibility.<fig id="Fig1"><label>Fig. 1</label><caption><p>PRISMA flow diagram</p></caption><graphic id="MO1" xlink:href="13099_2020_346_Fig1_HTML"></graphic></fig></p>
<p id="Par32">The inclusion criteria were studies pertaining to (1) children under the age of 18 years of age with clinically diagnosed ASD, (2) more than 10 enrolled participants, (3) gut microbiota with descriptive and inferential statistics, and (4) full text peer-viewed articles. Exclusion criteria included studies with non-human subjects, single case reports or reviews, participants with genetic disorders that were associated with a high prevalence of ASD (e.g. Rett syndrome), concomitant condition of major diseases of the intestinal tract, as well as publication date earlier than January 2000 or after May 2019. We used 10 as the cutoff for the number of participants in our inclusion criteria. This parameter was chosen to ensure sufficient heterogeneity in the sample and to reduce the possibility of Type II errors.</p>
<p id="Par33">Assessment of 23 articles for final inclusion was based on full text by authors L.H. and V.T. Disagreements on nine papers were resolved and arbitrated by authors E.C.L and N.S., and consensus was reached in all cases. Subsequently, the reference sections of all eligible articles were reviewed by E.C.L. and an additional three studies were found, which resulted in 26 articles.</p>
</sec>
<sec id="Sec6">
<title>Data extraction</title>
<p id="Par34">Data reported from each study were manually extracted from the full text articles to a database including: (1) study location, (2) study sample size for both case subjects and controls, (3) study type (longitudinal, cross-sectional, prospective, retrospective, randomized), (4) participant age range, (5) diagnostic criteria or assessment used, (6) molecular and microbiology methods, (7) interventions used, and (8) statistical results related to the gut microbiome. These were reported in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of data used for analyses in the 26 articles</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">Country</th><th align="left">No. of controls (GI status)</th><th align="left">Control: mean age ± SD; age range</th><th align="left">No. of cases analysed (GI status)</th><th align="left">Case: Mean age ± SD; age range</th><th align="left">ASD and behavioural tools</th><th align="left">Bacterial genome source</th><th align="left">Methods</th></tr></thead><tbody><tr><td align="left">Adams et al. [<xref ref-type="bibr" rid="CR30">30</xref>]</td><td align="left">USA</td><td align="left">39 HC (− GI)</td><td align="left">7.7 ± 4.4; 2.5–18</td><td align="left">58 (± GI)</td><td align="left">6.9 ± 3.4; 2.5–18</td><td align="left">ATEC</td><td align="left">Fecal</td><td align="left">Cultures, Vitek<sup>®</sup> 2 microbial identification system</td></tr><tr><td align="left">De Angelis et al. [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td align="left">Italy</td><td align="left">10 SIB (− GI)</td><td align="left">4–10</td><td align="left">20 (− GI)</td><td align="left">4–10</td><td align="left">DSM-IV, ADI-R, CARS, ADOS</td><td align="left">Fecal</td><td align="left">Cultures, bTEFAP of the 16S rDNA and 16S rRNA</td></tr><tr><td align="left">Finegold et al. [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td align="left">USA</td><td align="left">8 HC (n/a)</td><td align="left">n/a</td><td align="left">13 (+ GI)</td><td align="left">n/a</td><td align="left">n/a</td><td align="left"><p>Fecal</p><p>Gastric and duodenal fluids</p></td><td align="left">Cultures, 16S rRNA</td></tr><tr><td align="left">Finegold et al. [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td align="left">USA</td><td align="left"><p>7 SIB (± GI)</p><p>8 HC (± GI)</p></td><td align="left">2–13</td><td align="left">33 (± GI)</td><td align="left">2–13</td><td align="left">Expert evaluation</td><td align="left">Fecal</td><td align="left">bTEFAP of 16S rRNA gene at the DNA level</td></tr><tr><td align="left">Finegold et al. [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td align="left">USA</td><td align="left">13 HC (− GI)</td><td align="left">2–9</td><td align="left">33 (± GI)</td><td align="left">2–9</td><td align="left">n/a</td><td align="left">Fecal</td><td align="left">Cultures, PCR for the main <italic>C. perfringens</italic> toxins, verified with DNA sequencing</td></tr><tr><td align="left">Gondalia et al. [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left">Australia</td><td align="left">None</td><td align="left">n/a</td><td align="left">28 (± GI)</td><td align="left">4.8 ± 3.3; 2–14</td><td align="left">CARS, expert evaluation</td><td align="left">Fecal</td><td align="left">Cultures</td></tr><tr><td align="left">Gondalia et al. [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td align="left">Australia</td><td align="left">53 SIB (8% + GI)</td><td align="left">2–12</td><td align="left">51 (55% + GI)</td><td align="left">2–12</td><td align="left">CARS, expert evaluation</td><td align="left">Fecal</td><td align="left">bTEFAP Gray28F 5′TTTGATCNTGGCTCAG and Gray519r 5′ GTNTTACNGCGGCKGCTG, qPCR</td></tr><tr><td align="left">Inoue et al. [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left">Japan</td><td align="left">6 HC (− GI)</td><td align="left">3–5</td><td align="left">6 (− GI)</td><td align="left">3–5</td><td align="left">DSM-5, PARS, M-CHAT</td><td align="left"><p>Fecal</p><p>Blood</p></td><td align="left">16S rRNA, DNA microarray analysis of PBMC, qPCR</td></tr><tr><td align="left">Iovene et al. [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td align="left">Italy</td><td align="left">33 HC (− GI)</td><td align="left">7.3 ± 3.1</td><td align="left">47 (70% + GI)</td><td align="left">6.0 ± 2.8</td><td align="left">DSM-IV-TR, ADI-R, CARS, ADOS</td><td align="left">Fecal</td><td align="left">Cultures, Vitek<sup>®</sup> 2 microbial identification system</td></tr><tr><td align="left">Kang et al. [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left">USA</td><td align="left">20 HC (− GI)</td><td align="left">8.3 ± 4.4; 3–16</td><td align="left">20 (+ GI)</td><td align="left">6.7 ± 2.7; 3–16</td><td align="left">ADI-R, ADOS, ATEC, PDD-BI</td><td align="left">Fecal</td><td align="left">16S rRNA, bTEFAP 104F (59-GGCGVACGGGTGAGTA A-39) and 530R (59-CCGCNGCNGCT GGCAC-39)</td></tr><tr><td align="left">Kang et al. [<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left">USA</td><td align="left">20 HC (− GI)</td><td align="left">Age-matched</td><td align="left">18 (+ GI)</td><td align="left">7–16</td><td align="left">ADI-R, CARS, SRS, ABC, PGI-III, VABS</td><td align="left">Fecal</td><td align="left">16S rRNA</td></tr><tr><td align="left">Kang et al. [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left">USA</td><td align="left">21 HC (± GI)</td><td align="left">8.4 ± 3.4, 4–17</td><td align="left">23 (± GI)</td><td align="left">10.1 ± 4.1; 4–17</td><td align="left">ADI-R, ADOS, ATEC, PDD-BI</td><td align="left">Fecal</td><td align="left">16S rRNA, 104F (59-GGCGVACGGGTGAGTAA-39) and 530R (59-CCGCNGCNGCTGGCAC-39),</td></tr><tr><td align="left">Kushak et al. [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left">USA</td><td align="left">19 HC (+ GI)</td><td align="left">16.1 ± 1.3</td><td align="left">21 (+ GI)</td><td align="left">14.4 ± 1.1</td><td align="left">DSM-IV</td><td align="left">Duodenal biopsy</td><td align="left"><p>16S rRNA, Gray28F 50TTTGATCNTGGCTCAG</p><p>and Gray519r 50 GTNTTACNGCGGCKGCTG</p></td></tr><tr><td align="left">Liu et al. [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td align="left">China</td><td align="left">None</td><td align="left">n/a</td><td align="left">20 (n/a)</td><td align="left">1–8</td><td align="left">DSM-5, CARS, ABC, SRS</td><td align="left">Fecal</td><td align="left">16S rRNA, CD 38 and RORA mRNA, 338F 5′-ACTCCTACGGGAGGCAGCA-3′ and 806R 5′-GGACTACHVGGGTWTCTAAT-3′</td></tr><tr><td align="left">Luna et al. [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td align="left">USA</td><td align="left">21 HC (71% + GI)</td><td align="left"><p>3–18, + GI</p><p>3–14, -GI</p></td><td align="left">14 (+ GI)</td><td align="left">4–13</td><td align="left">SRS, ADOS</td><td align="left">Blood biopsy from colon</td><td align="left">V1V3 and V4 regions of the 16S ribosomal RNA</td></tr><tr><td align="left">Parracho et al. [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td align="left">UK</td><td align="left"><p>12 SIB (25% + GI)</p><p>10 HC (− GI)</p></td><td align="left"><p>6 ± 2.15, 2–10</p><p>6 ± 2.88, 3–12</p></td><td align="left">58 (91% + GI)</td><td align="left">7 ± 3.76; 3–16</td><td align="left">n/a</td><td align="left">Fecal</td><td align="left">FISH</td></tr><tr><td align="left">Parracho et al. [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td align="left">UK</td><td align="left">None</td><td align="left">n/a</td><td align="left">17 (± GI)</td><td align="left">4–16</td><td align="left">DBC-P</td><td align="left">Fecal</td><td align="left">FISH</td></tr><tr><td align="left">Shaaban et al. [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td align="left">Egypt</td><td align="left">30 HC (− GI)</td><td align="left">Age and gender-matched</td><td align="left">30 (− GI)</td><td align="left">7.1 ± 1.4; 5–9</td><td align="left">DSM-5, ADOS, ADI-R, ATEC, expert evaluation</td><td align="left">Fecal</td><td align="left">qPCR</td></tr><tr><td align="left">Son et al. [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td align="left">USA</td><td align="left">44 SIB (30% + GI)</td><td align="left"><p>10.0 ± 1.8</p><p>8–13</p></td><td align="left">59 (42% + GI)</td><td align="left">10.3 ± 1.8; 8–13</td><td align="left">ADI-R, ADOS, CBCL</td><td align="left">Fecal</td><td align="left">qPCR, V1V2 and V1V3 regions of 16S rRNA</td></tr><tr><td align="left">Song et al. [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td align="left">USA</td><td align="left">8 HC (n/a)</td><td align="left">n/a</td><td align="left">15 (n/a)</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">Fecal</td><td align="left">TaqMan qPCR of 16srRNA</td></tr><tr><td align="left">Strati et al. [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td align="left">Italy</td><td align="left">40 HC (27.5% + GI)</td><td align="left">9.2 ± 7.9</td><td align="left">40 (12.5% + GI)</td><td align="left">11.1 ± 6.8</td><td align="left">DSM-5, ADOS, ABC, CARS</td><td align="left">Fecal</td><td align="left">16S rRNA and ITS sequencing</td></tr><tr><td align="left">Tomova et al. [<xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left">Slovakia</td><td align="left"><p>9 SIB (78% + GI)</p><p>10 HC (60% + GI)</p></td><td align="left"><p>5–17</p><p>2–11</p></td><td align="left">10 (90% + GI)</td><td align="left">2–9</td><td align="left">ADI-R, CARS, expert evaluation</td><td align="left">Fecal</td><td align="left">qPCR</td></tr><tr><td align="left">Wang et al. [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td align="left">Australia</td><td align="left"><p>22 SIB (27% + GI)</p><p>9 HC (11% + GI)</p></td><td align="left"><p>12 ± 1 (4.6–18.4)</p><p>9.5 ± 1.3 (3.5–15.2)</p></td><td align="left">23 ( 39% + GI)</td><td align="left">10.3 ± 0.8; 3.1–17.3</td><td align="left">CARS, DSM-IV</td><td align="left">Fecal</td><td align="left">qPCR</td></tr><tr><td align="left">Wang et al. [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td align="left">Australia</td><td align="left"><p>22 SIB (27% + GI)</p><p>9 HC (11% + GI)</p></td><td align="left">3–19</td><td align="left">23 ( 39% + GI)</td><td align="left">3–19</td><td align="left">CARS, DSM-IV</td><td align="left">Fecal</td><td align="left">qPCR</td></tr><tr><td align="left">Williams et al. [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td align="left">USA</td><td align="left">7 HC (+ GI)</td><td align="left">4.0 ± 1.1; 3.9–5.5</td><td align="left">15 (+ GI)</td><td align="left">4.5 ± 1.3; 3.5–5.9</td><td align="left">DSM-IV-TR, ADI-R, shortened CPEA regression interview</td><td align="left">Biopsy from ileum and cecum</td><td align="left">16sRNA</td></tr><tr><td align="left">Williams et al. [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td align="left">USA</td><td align="left">9 HC (+ GI)</td><td align="left">n/a</td><td align="left">23 (+ GI)</td><td align="left">n/a</td><td align="left">DSM-IV-TR symptoms, ADI-R, shortened CPEA regression interview</td><td align="left">Biopsy from ileum and cecum</td><td align="left"><italic>Sutterella</italic>-specific 16S rRNA, qPCR</td></tr></tbody></table><table-wrap-foot><p>ABC = Autism Behaviour Checklist; ADI-R = Autism Diagnostic Interview-Revised; ADOS = Autism Diagnostic Observation Schedule; ATEC = Autism Treatment Evaluation Checklist; b-TEFAP = Bacterial tag-encoded FLX amplicon pyrosequencing; CARS = Childhood Autism Rating Scale score; CBCL = Child Behavior CheckList; CPEA = Collaborative Programs of Excellence in Autism; DBC-P = Developmental Behavior Checklist—Parent/Primary Carer; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-IV-R = Diagnostic and Statistical Manual of Mental Disorders, 4th edition text revised; DSM-5 = Diagnostic and Statistical Manual of Mental Disorders, 5th edition; FISH = fluorescence in situ hybridization; GI = gastrointestinal symptoms; GI (+) = GI symptoms present in the group; GI (−) = GI symptoms not present in the group; HC = Health controls; M-CHAT = Modified Checklist for Autism in Toddlers; n/a = not available; PBMC = Peripheral blood mononuclear cells; PARS = Pediatric Anxiety Rating Scale; PDD-BI = Pervasive Developmental Disorder Behavioral Inventory; PDD-NOS = Pervasive Developmental Disorder, not otherwise specified = Mild; PGI = Parent Global Impression; Severe = Autistic Disorder; SIB = Siblings without ASD, SRS = Social Responsiveness Scale; qPCR = quantitative Polymerase chain reaction, RORA = RAR Related Orphan Receptor A; rRNA = ribonucleic acid; VABS = Vineland Adaptative Behavior Scales</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec7">
<title>Quantification and statistical analysis</title>
<p id="Par35">All reported outcomes were organized into tables showing detailed differences in the gut microbiome from the phylum down to the species between case subjects with ASD and control groups. When studies implemented interventions, we also noted differences reported before and after the interventions. Results of each study were summarized as increased, decreased, or no change in relative abundance (percentage), absolute abundance (counts), or variety of each microorganism. To ensure a rigorous review, observational data without inferential statistics were not included. For results with statistical comparisons, both positive and negative findings were reported regardless of significance. When inferential statistics were completed yet no <italic>p-</italic>values or 95% confidence intervals could be found, the authors of this review used the data generated by the original authors and conducted tests of statistical significance. The majority of these tests included chi-square tests of independence for non-parametric, categorical data, two-sample and/or paired <italic>t</italic>-tests, and one-way analysis of variance (ANOVA). These analyses were completed using IBM SPSS Statistics, Version 22 (SPSS Inc., Chicago, IL).</p>
</sec>
</sec>
<sec id="Sec8">
<title>Results</title>
<p id="Par36">In total, 26 papers [<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR55">55</xref>] were selected for this systematic review (PRISMA Fig. <xref ref-type="fig" rid="Fig1">1</xref>; search criteria Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1). Two studies [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] belonged to the same cohort but were both included in the synthesis of this systematic review because the gut microbes examined were different.</p>
<p id="Par37">A summary of the papers used is provided in Table <xref ref-type="table" rid="Tab1">1</xref>, including methodological techniques and the rigor of how ASD had been diagnosed. The detailed results from each study are presented in different tables (Tables <xref ref-type="table" rid="Tab2">2</xref>, <xref ref-type="table" rid="Tab3">3</xref>, <xref ref-type="table" rid="Tab4">4</xref> and <xref ref-type="table" rid="Tab5">5</xref>), grouped according to bacterial taxonomic classification for easy comparison.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Changes in Bacteroidetes phylum between children with ASD and healthy controls</p></caption><graphic id="MO2" position="anchor" xlink:href="13099_2020_346_Tab2_HTML"></graphic><table-wrap-foot><p>Arrows indicate whether the strains are increased (⇑), reported as no significant difference (⇒), or decreased (⇓) in (1) count (light grey), (2) percentage of the total microbiota (dark grey), and (3) variety (black); single arrow denoting <italic>p</italic> &lt; 0.05, double arrows denoting <italic>p</italic> &lt; 0.01</p><p>HC = healthy controls; SIB = sibling without ASD; Autistic Disorder = Severe; Pervasive Developmental Disorder, not otherwise specified (PDD-NOS) = Mild</p><p><sup>a</sup>Described in text without definitive <italic>p-</italic>values</p><p><sup>b</sup>Ages 13–18 only</p><p><sup>c</sup>Ages below 6 only</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Changes in Firmicutes phylum between children with ASD and healthy controls</p></caption><graphic id="MO3" position="anchor" xlink:href="13099_2020_346_Tab3a_HTML"></graphic><graphic id="MO12" position="anchor" xlink:href="13099_2020_346_Tab3b_HTML"></graphic><table-wrap-foot><p>Arrows indicate whether the strains are increased (⇑), reported as no significant difference (⇒), or decreased (⇓) in (1) count (light grey), (2) percentage of the total microbiota (dark grey), and (3) variety (black); single arrow denoting <italic>p</italic> &lt; 0.05, double arrows denoting <italic>p</italic> &lt; 0.01</p><p>HC = healthy controls; SIB = sibling without ASD; Autistic Disorder = Severe; Pervasive Developmental Disorder, not otherwise specified (PDD-NOS) = Mild</p><p><sup>a</sup>Described in text without definitive <italic>p-</italic>values</p><p><sup>b</sup>Ages 13–18 only</p><p><sup>c</sup>Ages below 6 only</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Changes in Proteobacteria, Actinobacteria, Fusobacteria, and Verrucomicrobia phyla between children with ASD and healthy controls.</p></caption><graphic id="MO4" position="anchor" xlink:href="13099_2020_346_Tab4a_HTML"></graphic><graphic id="MO10" position="anchor" xlink:href="13099_2020_346_Tab4b_HTML"></graphic><table-wrap-foot><p>Arrows indicate whether the strains are increased (⇑), reported as no significant difference (⇒), or decreased (⇓) in (1) count (light grey), (2) percentage of the total microbiota (dark grey), and (3) variety (black); single arrow denoting <italic>p</italic> &lt; 0.05, double arrows denoting <italic>p</italic> &lt; 0.01</p><p>HC = healthy controls; SIB = sibling without ASD; Autistic Disorder = Severe; Pervasive Developmental Disorder, not otherwise specified (PDD-NOS) = Mild</p><p><sup>a</sup>Described in text without definitive <italic>p-</italic>values</p><p><sup>b</sup>V1V2 datasets are statistically significant, but not V1V3</p><p><sup>c</sup>V1V3 datasets are statistically significant, but not V1V2</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Changes in Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria after intervention</p></caption><graphic id="MO5" position="anchor" xlink:href="13099_2020_346_Tab5_HTML"></graphic><table-wrap-foot><p>Arrows indicate whether the strains are increased (⇑), reported as no significant difference (⇒), or decreased (⇓) in (1) count (light grey), (2) percentage of the total microbiota (dark grey), and (3) variety (black); single arrow denoting p &lt; 0.05, double arrows denoting p &lt; 0.01</p><p>HC = healthy controls; SIB = sibling without ASD; Autistic Disorder = Severe; Pervasive Developmental Disorder, not otherwise specified (PDD-NOS) = Mild</p><p><sup>a</sup>Described in text without definitive p-values</p></table-wrap-foot></table-wrap></p>
<sec id="Sec9">
<title>Changes to alpha and beta diversity</title>
<p id="Par38">In metagenomics, alpha diversity represents the richness and the diversity of the microbiome in a single ecosystem. QIIME Operating taxonomic unit (OTU) counts, Chaos1, and Shannon index are commonly used to calculate alpha diversity. Based on the results of 11 papers that examined alpha diversity, there were no consistent patterns when comparing alpha diversity in children with ASD versus alpha diversity in siblings (SIB) and healthy controls (HC; Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2). Two studies showed increases [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] and six studies showed no significant changes in alpha diversity [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The last three studies indicated decreases; however, the studies came from one laboratory [<xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR41">41</xref>].</p>
<p id="Par39">Beta diversity refers to the total variance in microbial community composition across varying environments. Bray–Curtis dissimilarity, Jaccard distance, and UniFrac are examples of indices used in the calculation. Among the seven [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] papers that reported on beta diversity, four [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] papers showed significant differences in beta diversity between ASD and SIB/HC while the rest did not (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2).</p>
</sec>
<sec id="Sec10">
<title>Changes to Bacteroidetes</title>
<p id="Par40">Six studies provided results on Bacteroidetes at the phylum level (Table <xref ref-type="table" rid="Tab2">2</xref>). Only one study [<xref ref-type="bibr" rid="CR33">33</xref>] demonstrated an increase in the percentage of Bacteroidetes in children with ASD, classified as “severe”, compared to HC (<italic>p</italic> = 0.001). Authors of this current review used data from this one study [<xref ref-type="bibr" rid="CR33">33</xref>] and conducted <italic>t</italic>-tests to compare children labeled as “mild” against HC. We found that despite having “mild” ASD in the study, the percentage of Bacteroidetes in these children was still significantly increased compared to controls (<italic>p</italic> = 0.0012). The rest of the studies observed either a decrease in Bacteroidetes percentage [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] or no significant differences between cases and controls [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR48">48</xref>].</p>
<p id="Par41">Fifteen studies reported findings at the genus and/or species level of Bacteroidetes. Similar to the phylum Bacteroidetes as a whole, results from these studies were not consistent. The only genus with a more recognisable pattern was <italic>Prevotella.</italic> Seven out of fifteen studies described <italic>Prevotella</italic> and none of them showed a higher relative abundance in the stools of children with ASD when compared to controls. Instead, these seven studies showed either a non-significant result in relative abundance [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] or a lower relative abundance in children classified as ASD versus SIB or HC [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. There was no specific pattern in the absolute abundance of <italic>Prevotella.</italic> For all other genera and species (Table <xref ref-type="table" rid="Tab2">2</xref>), studies generally contradicted each other and different laboratories found varying composition of Bacteroidetes species.</p>
<p id="Par42">The other 24 detected species in the Bacteroidetes phyla were described in only one study each; hence, no summary could be made. However, we have included the results of all these species in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S3.</p>
</sec>
<sec id="Sec11">
<title>Changes to Firmicutes</title>
<p id="Par43">Table <xref ref-type="table" rid="Tab3">3</xref> shows changes in the phylum of Firmicutes. At the phylum level, none of the six studies showed an increase in absolute or relative abundance [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The two studies on absolute abundance did not reveal any differences between ASD, SIB, and HC [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. For relative abundance in both total and metabolically active Firmicutes, the studies demonstrated either a decrease [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] or no significant differences between children with ASD, SIB, and HC [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p>
<p id="Par44">Interestingly, from a Clostridiales cluster standpoint, the studies on Cluster I and Cluster II, as well as Cluster XI, while few, collectively suggested an increase in children with ASD [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Studies with negative findings were present, although none of the studies showed a decrease in these Clostridiales clusters. <italic>Clostridium perfringens</italic> at a species level had evidence for increased absolute and relative abundance in children with ASD versus typically developing children [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Cluster XIVa and XIVb, however, were quantitatively similar in percentage [<xref ref-type="bibr" rid="CR52">52</xref>] and counts [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>] in the available four studies. Many studies have focused on <italic>Clostridium</italic> as a genus and the method of addressing <italic>Clostridium</italic> quantity were not the same, with four studies using the number of counts, three using percentage of the total microbiota, and one using diversity within the genus as outcomes. The differences in methodology render the meta-analysis of these studies inconclusive.</p>
<p id="Par45">In the families of <italic>Eubacteriaceae</italic>, <italic>Christensenellaceae</italic>, <italic>Lachnospiraceae</italic>, and <italic>Ruminococcaceae</italic>, the results were inconsistent. In the order Lactobacillales and family <italic>Streptococcaceae</italic>, <italic>Streptococcus</italic> results (not <italic>S. thermophilus</italic>) corroborated an overall decrease in counts and percentage in ASD cases when statistical significance was reached [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. <italic>Staphylococcus</italic> species were not extensively studied.</p>
<p id="Par46">An additional 83 species were reported in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S4. As there was a paucity of studies published on these species, no firm conclusions could be made.</p>
</sec>
<sec id="Sec12">
<title>Changes in Proteobacteria, Enterobacteria, Actinobacteria, and other phyla</title>
<p id="Par47">Members of the phylum Proteobacteria have a low abundance in the gut of healthy humans. However, several studies have observed correlations between an increase in abundance of Proteobacteria and diseased states [<xref ref-type="bibr" rid="CR56">56</xref>]. As such, results from studies which measured changes to Proteobacteria were synthesised and presented in Table <xref ref-type="table" rid="Tab4">4</xref>.</p>
<p id="Par48">At the phylum level, no significant differences were observed in Proteobacteria between the two groups except one study indicated an increase in percentage [<xref ref-type="bibr" rid="CR33">33</xref>]. Despite speculation that <italic>Sutterella</italic> was increased in children with ASD [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], this was not true in every study. There were three studies suggesting no significant differences [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] and one suggesting a decrease [<xref ref-type="bibr" rid="CR44">44</xref>], but this particular study included adolescents in their cohort.</p>
<p id="Par49">There were insufficient studies examining the family <italic>Enterobacteriaceae</italic>. The general trend, however, supports no alterations in <italic>E. coli</italic> for children in ASD in five studies [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] vs one study [<xref ref-type="bibr" rid="CR31">31</xref>] documenting a decrease in <italic>E. coli</italic> percentage among other microbiota. Actinobacteria as a phylum did not reveal any compelling results [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]; however, upon a closer look at <italic>Bifidobacterium</italic>, consistently lower counts and proportions were found in children with ASD versus their siblings [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] or controls [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Only one study with a small sample size of 10 children with ASD contradicted this finding [<xref ref-type="bibr" rid="CR51">51</xref>]. In this study, participants’ microbiome composition were likely different, as they were all from the eastern region of Central Europe and their diets might consist of different dairy products like sheep cheese and sour milk.</p>
<p id="Par50">Fusobacteria phylum suggested a lower relative abundance in children with ASD vs unaffected siblings, although one study [<xref ref-type="bibr" rid="CR48">48</xref>] demonstrated the opposite in terms of <italic>Fusobacterium</italic> absolute numbers. No specific findings were identified in the Verrucomicrobia phylum [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] and in the <italic>Verrucomicrobiaceae</italic> family [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
<p id="Par51">Within these phyla, 42 additional bacterial species were described by the 26 studies, but were either unclassified or only measured by one study. We have listed positive and negative findings of each species in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S5. However, no comparisons or conclusions could be made from the limited number of studies on each species.</p>
</sec>
<sec id="Sec13">
<title>Intervention studies involving a change in abundance of bacterial subtypes</title>
<p id="Par52">The growing focus on the gut-brain axis led many researchers to perform studies which aimed to identify ways where the reversal of alterations in the gut microbiome could produce therapeutic effects on ASD symptoms, such as by administering probiotics or by changing diets of children with ASDs.</p>
<p id="Par53">One study investigated the effect of administering vitamin A [<xref ref-type="bibr" rid="CR43">43</xref>] on children with ASD and found an increase in abundance on the Bacteroidetes phylum level (Table <xref ref-type="table" rid="Tab5">5</xref>). Both <italic>Bacteroides</italic> species and <italic>Prevotella</italic> species levels increased post-treatment. On the other hand, all of the other phyla and genera measured showed a decrease in abundance. Post-vitamin A administration, significant increases were also seen in other forms of biomarkers, including plasma retinol, CD38 and RORA mRNA levels. However, no changes were seen in the ASD symptomatology of the study participants [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
<p id="Par54">Three other studies [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] examined the effects of probiotics on gut microbiome composition. The first one [<xref ref-type="bibr" rid="CR46">46</xref>] showed that probiotics consisting of <italic>Lactobacillus plantarum</italic> WCSD1 decreased the bacterial counts of Clostridium clusters XIVa and XIVb and increased <italic>Lactobacillus</italic> species. However, behavioral improvements on ASD children, as reported on the Development Behaviour Checklist, were not significantly different between the probiotic feeding and placebo regimes. In another study where probiotics consisting of <italic>L. acidophilus</italic>, <italic>L. rhamnosus</italic>, and <italic>Bifidobacteria longum</italic> were used, both <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic> species increased [<xref ref-type="bibr" rid="CR47">47</xref>]. Contrary to the first study, significant improvements in the severity of autism, as assessed by the Autism Treatment Evaluation Checklist (ATEC), were found in this second study. In the third study involving probiotic supplementation with Lactobacillus 60%, Bifidumbacteria 25%, Streptococcus 15% [<xref ref-type="bibr" rid="CR51">51</xref>], a decrease in Firmicutes phylum and <italic>Desulfovibrio</italic> was observed after probiotics intervention. Surprisingly, a decrease in <italic>Bifidobacterium</italic> was found after probiotics and no significant changes were found in the <italic>Lactobacillus</italic> species, which contradicted aforementioned studies [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. This third study did not describe the therapeutic effects of probiotics on ASD behaviors [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
<p id="Par55">Microbiota transfer therapy (MTT) was also performed in a recent study and bacterial composition before and after MTT treatment were collected. After MTT intervention, an increase in the absolute abundance of <italic>Prevotella</italic>, <italic>Bifidobacterium,</italic> and <italic>Desulfovibrio</italic> species was observed. Additionally, clinical assessments showed that behavioral ASD symptoms improved significantly and remained improved 8 weeks after treatment ended [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p id="Par56">Comparing changes in species across the various interventional studies, only <italic>Lactobacillus</italic> and <italic>Prevotella</italic> species showed a more consistent increase after probiotics interventions. However, it is important to note that each study used probiotics of different bacterial species. As such, purposeful conclusions cannot be drawn directly for comparison.</p>
</sec>
</sec>
<sec id="Sec14">
<title>Discussion</title>
<p id="Par57">In the works reviewed, children diagnosed with ASD have various forms of dysregulation of the microbiome when compared to siblings or unrelated children without the ASD profile. Since each individual study describes a restricted and different bacterial composition, direct comparison between strains with similar classification is limited. However, the data follow a more consistent pattern for a few strains. Relative and absolute Clostridia clusters I, II, and XI are not found to be decreased in the gut microbiome of children with ASD when compared to those without. Similarly, the relative and absolute abundances of Firmicutes at the phylum level, <italic>Streptococcus</italic> at the genus level, <italic>Prevotella</italic> species, and <italic>Bifidobacterium</italic> species are not increased in children with ASD versus non-sibling controls. Of note, in all studies reviewed including intervention ones, the absolute abundance of <italic>Bifidobacterium</italic> species is significantly decreased in children with ASD compared to non-sibling controls, and the species is also significantly increased after intervention. Despite some recognizable patterns, the majority of microorganisms reviewed from phyla to species have disparate results across different studies. Hence, to date, gut microbial composition by itself does not provide a predictive biomarker for ASD and the single technology of high-throughput sequencing will need to be integrated with multiple sources of omics data (e.g. proteomics, transcriptomics, metabolomics, microRNAs and exosomes) to produce potential signatures for the spectrum of symptoms in individuals with ASD.</p>
<p id="Par58">Although a direct causal mechanism of microbiome in the etiology of ASD in humans cannot be validated at this time, the gut microbiome likely alters brain functions through various other mechanisms, including environmental factors (e.g. in utero exposure to infection, maternal conditions, and medications), host genetics, host immune response regulation [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], excretion of metabolites such as tyrosine analogues, p-cresol, 4-ethylphenylsulfate, indoles, lipopolysaccharides and free amino acids [<xref ref-type="bibr" rid="CR59">59</xref>-<xref ref-type="bibr" rid="CR62">62</xref>], regulation of neurotransmitters and their receptors [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], or neuroactive compounds [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR64">64</xref>].</p>
<p id="Par59">Alterations of the host immune responses by gut microbiota are closely linked to ASD-related symptoms. The implicated cytokine pathways include, and not limited to, IL-5, IL-15, IL-17, IL-17a, IL-10, IL-1b, TNF-α, TGF-β1 and IFNγ [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Interestingly, the gut microbiota has recently been shown to influence the immune system directly via activation of the vagus nerve [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]. Furthermore, gut microbiota-derived short-chain fatty acids (SCFAs), such as propionic acid [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>] and butyric acid [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>], produced by bacterial fermentation of carbohydrates have immunomodulatory properties, e.g. upregulating genes associated with immune activation [<xref ref-type="bibr" rid="CR69">69</xref>], regulating T cells and cytokine production [<xref ref-type="bibr" rid="CR70">70</xref>], microglia homeostasis during developmentally sensitive periods [<xref ref-type="bibr" rid="CR73">73</xref>], and neuronal excitability [<xref ref-type="bibr" rid="CR74">74</xref>], and have recently been used in vivo in the treatment of inflammatory conditions such as inflammatory bowel diseases [<xref ref-type="bibr" rid="CR75">75</xref>]. In addition to understanding microbiome composition differences in children with ASD, there is a need to investigate the patterns of dysregulation in their immune responses as well as to look more upstream at the maternal immune response during pregnancy. Prior literature has substantiated that infections during pregnancy have been correlated with increased frequency of neurodevelopmental disorders in offspring [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]. Specifically, there is an association between ASD and maternal infection requiring hospitalization during pregnancy, elevated C-reactive protein, and a family history of autoimmune diseases. Thus, future studies will need to explain the bidirectional and possibly transgenerational roles of microbiome alterations and immune pathways on behaviours.</p>
<p id="Par60">A promising development in this field points to the need to consider interactions between host genetics and microbial composition. Differences in microbiome diversity have been shown to be partially attributed by genotype and sex [<xref ref-type="bibr" rid="CR79">79</xref>–<xref ref-type="bibr" rid="CR83">83</xref>]. In a rodent model, Tabouy et al. [<xref ref-type="bibr" rid="CR84">84</xref>] used the Shank3 KO mice and demonstrated that specific bacterial species (i.e. <italic>L. reuteri</italic>) were sensitive to an autism-related mutation, were decreased in abundance, and positively correlated with the expression of gamma-aminobutyric acid (GABA) receptor in the brain. Treatment with <italic>L. reuteri</italic> resulted in an increase of both GABA receptor gene expression and protein levels in brain regions of mice, which also corresponded to improvements in social engagement. It is noteworthy to mention that there is a paucity of research examining the interactions of host genetics and microbial dysregulation in humans with ASD. Perhaps it is worthwhile to isolate individuals with the same autism-related genotype and investigate for potential dysbiosis in their microbiome, along with changes in gene expression and/or in brain structure. Likewise, studies suggesting therapeutic potential for probiotic treatment has currently looked at individuals with the ASD profile as a whole. Future studies may consider subgroup analysis (e.g. responders vs non-responders) to understand the potential differences between subgroups.</p>
<p id="Par61">Lastly, the gut microbiome’s contribution to neurological development and regulation has been implicated and demonstrated in animal models [<xref ref-type="bibr" rid="CR85">85</xref>]. For example, gnotobiotic animals demonstrate heightened hypothalamic-pituitary response, elevated plasma adrenocorticotropic hormone and corticosterone, and reduced brain-derived neurotrophic factor (BDNF) expression levels in the cortex and hippocampus [<xref ref-type="bibr" rid="CR86">86</xref>]. Absence of colonization results in differential expression of proteins involved in synaptogenesis [<xref ref-type="bibr" rid="CR87">87</xref>] and atypical development [<xref ref-type="bibr" rid="CR88">88</xref>]. Subsequent microbial colonization reverses these processes. Furthermore, gut microbiota manufactures neuroactive chemicals and influences levels of circulating 5-hydroxytryptamine (5-HT) and serotonin, thereby altering fetal neuronal cell synaptogenesis [<xref ref-type="bibr" rid="CR89">89</xref>] and neuronal morphogenesis [<xref ref-type="bibr" rid="CR90">90</xref>], respectively. Although mounting evidence is accumulating for microbiome’s role in neural development, the precise nature of how multiple systems interact or overlap remain poorly defined.</p>
<p id="Par62">The variety of protocols for sampling and characterization of microbial ecology among included studies also warrant discussion. Since the human microbiome exhibits considerable spatial and temporal variability, single samples obtained from a specific anatomical site may not be representative of its true diversity at any given time and may especially fail to capture rarer or less abundant taxa. Heterogeneity also exists with regards to workflows for specimen storage and processing, and factors such as shipping time and ambient temperature are established to influence the microbial composition in poorly-handled specimens. In terms of experimental procedures, high-throughput nucleic acid-based interrogation represent the most common technique used in included studies. However, interpretation of the collective results across studies may be constrained by the lack of standardization of experimental protocols and is further hampered by suboptimal inter-platform agreement and measurement reliability. Finally, with regards to the comparison of microbial constituents between ASD cases and controls, the issue of multiple testing looms large. For these and other reasons, it is essential that the salient findings summarized in the present review are externally validated by independent laboratories.</p>
<p id="Par63">Autism spectrum disorder is a neurobiological disorder which is potentially a result of disruptions in normal brain growth very early in development. The studies reviewed have not reported on the birth or pre-diagnosis microbiome of children with ASD. Instead, studies generally report bacterial diversity after children are diagnosed with ASD. It is hard to determine the directionality of the association between microbiome differences and dietary habits. It is possible that children with ASD have greater likelihood of having more unique preferences in certain diets and this limited diet variety may account for microbiome differences. One study suggests that children with ASD may have an increased intake of chia seeds in smoothies, which is associated with specific microbiome findings [<xref ref-type="bibr" rid="CR48">48</xref>]. Children with ASD are also sometimes placed on non-specific gluten-free, casein-free diets, which easily change one’s gut microbiome composition.</p>
<p id="Par64">The literature currently lacks prospective studies that follow a child from prior to ASD diagnosis, preferably as an infant, with repeated objective assessment of ASD symptomatology and its trajectory at the same time as stool collection for microbiome. Given the long duration of such prospective studies, it is unlikely that the same environmental conditions such as diet, exposure to antibiotics or other medications, pets in the home, exposure to livestock, and limits on travel may be imposed on the participants, which will further complicate interpretation of microbial samples. Nonetheless, ongoing investigations, such as the National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) study, have already started the collection of infant microbiotas with planned serial samples. When these studies are complemented with mechanistic experiments in animal models, they can be powerful in giving insight into human biology.</p>
<p id="Par65">Research studies of this kind requires the involvement of professionals with clinical expertise in children with ASD. In this review, only a few studies have involved developmental specialists and psychologists who are apt in monitoring changes in ASD symptoms [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Parent-reported questionnaires, while important to provide a summary of behaviors within the home setting, are not as objective compared to experienced observations in standardized assessments by psychologists or developmental-behavioral pediatricians. The heterogeneous nature of ASD is also a challenge in review studies. Further, the diagnostic criteria for ASD and classification of ASD into subtypes have been updated in 2013. Older studies classifying children into Asperger Disorder, PDD-NOS, and Autistic Disorder are based on the older edition of DSM-IV and not the DSM-5. There are studies to support that these diagnoses do not translate directly to an ASD diagnosis on DSM-5 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. Future studies should consider a rigorous diagnosis of ASD and a description of the variety of ASD symptomatology in the participants, along with documentation of diet, intake of probiotics, antibiotics, travels, and episodes of gastrointestinal symptoms.</p>
<p id="Par66">In summary, we provide data to show that the current literature on dysbiosis in children with ASD does not provide a predictive signature for the condition or symptoms. However, researchers may take note of the general consistencies found in composition changes of <italic>Prevotella</italic>, Firmicutes as a whole, three Clostridia clusters, <italic>C. perfringens,</italic> and <italic>Bifidobacterium</italic> in children with ASD to design future studies and to look deeper into the influence of these microorganisms on multi-system pathways.</p>
<p id="Par67">The relationship of the microbiome and social behaviors is multifaceted and complex involving not only environmental factors and immune responses, but also the genetic background of the host. Further suggestions for future research include confirming the potential therapeutic qualities of specific microbial reconstitution in humans, dissecting the overlapping pathways between the microbiome and various organ systems, as well as the use of microbial metabolome and other omics platforms to study this topic.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec18">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13099_2020_346_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: Table S1.</bold> Search criteria, inclusion and exclusion criteria. <bold>Table S2.</bold> Differences between alpha and beta diversities. <bold>Table S3.</bold> Bacteroidetes phylum, single observation studies. <bold>Table S4.</bold> Firmicutes phylum, single observation studies. <bold>Table S5.</bold> Proteobacteria phylum, single observation studies.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AD</term>
<def>
<p id="Par5">Autistic Disorder</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par6">autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p id="Par7">brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>DSM-IV</term>
<def>
<p id="Par8">Diagnostic and Statistical Manual for Mental Disorder—Fourth Edition</p>
</def>
</def-item>
<def-item>
<term>ECHO</term>
<def>
<p id="Par9">Environmental influences on Child Health Outcomes</p>
</def>
</def-item>
<def-item>
<term>GABA</term>
<def>
<p id="Par10">gamma-aminobutyric acid</p>
</def>
</def-item>
<def-item>
<term>HC</term>
<def>
<p id="Par11">healthy controls</p>
</def>
</def-item>
<def-item>
<term>MIA</term>
<def>
<p id="Par12">maternal immune activation</p>
</def>
</def-item>
<def-item>
<term>MTT</term>
<def>
<p id="Par13">microbiota transfer therapy</p>
</def>
</def-item>
<def-item>
<term>NIH</term>
<def>
<p id="Par14">National Institutes of Health</p>
</def>
</def-item>
<def-item>
<term>ANOVA</term>
<def>
<p id="Par15">one-way analysis of variance</p>
</def>
</def-item>
<def-item>
<term>OTU</term>
<def>
<p id="Par16">operating taxonomic unit</p>
</def>
</def-item>
<def-item>
<term>PDD-NOS</term>
<def>
<p id="Par17">Pervasive Developmental Disorder, not otherwise specified</p>
</def>
</def-item>
<def-item>
<term>PRISMA</term>
<def>
<p id="Par18">Preferred Reporting Items for Systematic Reviews and Meta-analyses</p>
</def>
</def-item>
<def-item>
<term>SIB</term>
<def>
<p id="Par19">siblings</p>
</def>
</def-item>
<def-item>
<term>SCFAs</term>
<def>
<p id="Par20">short-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>5-HT</term>
<def>
<p id="Par21">5-hydroxytryptamine</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher's Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13099-020-0346-1.</p>
</sec>
<ack>
<p>We thank Dr. Dimple Rajgor for her assistance in editing, formatting and in submitting the manuscript for publication</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>Conceptualization—ECNL, PAT, SKHT; Methodology—ECNL, ET, NN; Validation—TJWV, NS; Formal analysis—ECNL, LHKH; Investigation—LHKH, TJWV, NS; Data curation—LHKH, TJWV, NS; Writing original draft—LHKH; Writing-review and editing—TJWV, NS, NN, ET, SKHT, PAT, ECNL; Supervision—ECNL, PAT, SKHT. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The study dataset was generated using the 26 articles stated in Table <xref ref-type="table" rid="Tab1">1</xref>. The datasets supporting the current study were extracted by authors of this review and they are all shown in the published tables.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p>Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<source/>DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5
          <year>2013</year>
<edition>5</edition>
<publisher-loc>Arlington</publisher-loc>
<publisher-name>American Psychiatric Association</publisher-name>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wiggins</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maenner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of Autism Spectrum Disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2014</article-title>
<source/>Morb Mortal Wkly Rep Surveill Summ
          <year>2018</year>
<volume>67</volume>
<issue>6</issue>
<fpage>1</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baxter</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brugha</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Erskine</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Scheurer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The epidemiology and global burden of autism spectrum disorders</article-title>
<source/>Psychol Med
          <year>2015</year>
<volume>45</volume>
<issue>3</issue>
<fpage>601</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1017/S003329171400172X</pub-id>
<pub-id pub-id-type="pmid">25108395</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Auyeung</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism prevalence in China is comparable to Western prevalence</article-title>
<source/>Mol Autism
          <year>2019</year>
<volume>1</volume>
<issue>10</issue>
<fpage>1</fpage>
<lpage>19</lpage>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Laska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>EC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of autism spectrum disorders in a total population sample</article-title>
<source/>Am J Psychiatry
          <year>2011</year>
<volume>168</volume>
<issue>9</issue>
<fpage>904</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101532</pub-id>
<pub-id pub-id-type="pmid">21558103</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsabbagh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Divan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Kauchali</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marcin</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global prevalence of autism and other pervasive developmental disorders</article-title>
<source/>Autism Res
          <year>2012</year>
<volume>5</volume>
<issue>3</issue>
<fpage>160</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1002/aur.239</pub-id>
<pub-id pub-id-type="pmid">22495912</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyall</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fallin</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Ladd-Acosta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The changing epidemiology of autism spectrum disorders</article-title>
<source/>Annu Rev Public Health
          <year>2017</year>
<volume>38</volume>
<fpage>81</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-publhealth-031816-044318</pub-id>
<pub-id pub-id-type="pmid">28068486</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tordjman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Somogyi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Coulon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kermarrec</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bronsard</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene × environment interactions in autism spectrum disorders: role of epigenetic mechanisms</article-title>
<source/>Front Psychiatry.
          <year>2014</year>
<volume>5</volume>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00053</pub-id>
<pub-id pub-id-type="pmid">25136320</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hsien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>7</issue>
<fpage>1451</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannion</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leader</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Gastrointestinal symptoms in autism spectrum disorder: a literature review</article-title>
<source/>Rev J Autism Dev Disord
          <year>2014</year>
<volume>1</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1007/s40489-013-0007-0</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaidez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Gastrointestinal problems in children with autism, developmental delays or typical development</article-title>
<source/>J Autism Dev Disord
          <year>2014</year>
<volume>44</volume>
<issue>5</issue>
<fpage>1117</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-013-1973-x</pub-id>
<pub-id pub-id-type="pmid">24193577</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Serena</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sturgeon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Careaga</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms</article-title>
<source/>Brain Behav Immun
          <year>2018</year>
<volume>70</volume>
<fpage>354</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2018.03.025</pub-id>
<pub-id pub-id-type="pmid">29571898</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howlin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Magiati</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorder: outcomes in adulthood</article-title>
<source/>Curr Opin Psychiatry
          <year>2017</year>
<volume>30</volume>
<issue>2</issue>
<fpage>69</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1097/YCO.0000000000000308</pub-id>
<pub-id pub-id-type="pmid">28067726</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buescher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cidav</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Costs of autism spectrum disorders in the United Kingdom and the United States</article-title>
<source/>JAMA Pediatr
          <year>2014</year>
<volume>168</volume>
<issue>8</issue>
<fpage>721</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="doi">10.1001/jamapediatrics.2014.210</pub-id>
<pub-id pub-id-type="pmid">24911948</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker-Athill</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway</article-title>
<source/>Neuro-Signals
          <year>2010</year>
<volume>18</volume>
<issue>2</issue>
<fpage>113</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1159/000319828</pub-id>
<pub-id pub-id-type="pmid">20924155</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atladóttir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thorsen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Østergaard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schendel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lemcke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abdallah</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders</article-title>
<source/>J Autism Dev Disord
          <year>2010</year>
<volume>40</volume>
<issue>12</issue>
<fpage>1423</fpage>
<lpage>1430</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-010-1006-y</pub-id>
<pub-id pub-id-type="pmid">20414802</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sourander</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hinkka-Yli-Salomäki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McKeague</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sundvall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Surcel</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Elevated maternal C-reactive protein and autism in a national birth cohort</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>2</issue>
<fpage>259</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.197</pub-id>
<pub-id pub-id-type="pmid">23337946</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berrios</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lafourcade</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pascual</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reversing behavioural abnormalities in mice exposed to maternal inflammation</article-title>
<source/>Nature
          <year>2017</year>
<volume>549</volume>
<issue>7673</issue>
<fpage>482</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1038/nature23909</pub-id>
<pub-id pub-id-type="pmid">28902835</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atarashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring</article-title>
<source/>Nature
          <year>2017</year>
<volume>549</volume>
<issue>7673</issue>
<fpage>528</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1038/nature23910</pub-id>
<pub-id pub-id-type="pmid">28902840</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desbonnet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Traplin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O'Sullivan</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Crispie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Moloney</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour</article-title>
<source/>Brain Behav Immun
          <year>2015</year>
<volume>48</volume>
<fpage>165</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2015.04.004</pub-id>
<pub-id pub-id-type="pmid">25866195</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buffington</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Auchtung</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ajami</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Costa-Mattioli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<issue>7</issue>
<fpage>1762</fpage>
<lpage>1775</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27315483</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grenham</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scully</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Moloney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>6</issue>
<fpage>666</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.77</pub-id>
<pub-id pub-id-type="pmid">22688187</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogbonnaya</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O'Leary</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Adult hippocampal neurogenesis is regulated by the microbiome</article-title>
<source/>Biol Psychiat
          <year>2015</year>
<volume>78</volume>
<issue>4</issue>
<fpage>e7</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.12.023</pub-id>
<pub-id pub-id-type="pmid">25700599</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Veeraragavan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Engevik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Balderas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Runge</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal colonization with human "infant-type" <italic>Bifidobacterium</italic> species alters behavior of adult gnotobiotic mice</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<issue>5</issue>
<fpage>e0196510-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0196510</pub-id>
<pub-id pub-id-type="pmid">29763437</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deboy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Eckburg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metagenomic analysis of the human distal gut microbiome</article-title>
<source/>Science
          <year>2006</year>
<volume>312</volume>
<issue>5778</issue>
<fpage>1355</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="doi">10.1126/science.1124234</pub-id>
<pub-id pub-id-type="pmid">16741115</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Firmesse</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Levenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guimarăes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Doré</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age</article-title>
<source/>BMC Microbiol
          <year>2009</year>
<volume>9</volume>
<fpage>123</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-9-123</pub-id>
<pub-id pub-id-type="pmid">19508720</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlson</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Azcarate-Peril</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Styner</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Infant gut microbiome associated with cognitive development</article-title>
<source/>Biol Psychiatry
          <year>2018</year>
<volume>83</volume>
<issue>2</issue>
<fpage>148</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.06.021</pub-id>
<pub-id pub-id-type="pmid">28793975</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vuong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Emerging roles for the gut microbiome in autism spectrum disorder</article-title>
<source/>Biol Psychiatry
          <year>2017</year>
<volume>81</volume>
<issue>5</issue>
<fpage>411</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.024</pub-id>
<pub-id pub-id-type="pmid">27773355</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borre</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>O'Keeffe</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title>
<source/>Trends Mol Med
          <year>2014</year>
<volume>20</volume>
<issue>9</issue>
<fpage>509</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2014.05.002</pub-id>
<pub-id pub-id-type="pmid">24956966</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Quig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity</article-title>
<source/>BMC Gastroenterol
          <year>2011</year>
<volume>11</volume>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1471-230X-11-22</pub-id>
<pub-id pub-id-type="pmid">21410934</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vannini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Siragusa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Serrazzanetti</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>10</issue>
<fpage>e76993-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0076993</pub-id>
<pub-id pub-id-type="pmid">24130822</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Molitoris</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vaisanen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal microflora studies in late-onset autism</article-title>
<source/>Clins Infect Dis
          <year>2002</year>
<volume>35</volume>
<issue>Suppl 1</issue>
<fpage>S6</fpage>
<lpage>S16</lpage>
<pub-id pub-id-type="doi">10.1086/341914</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dowd</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gontcharova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Henley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wolcott</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>
<source/>Anaerobe
          <year>2010</year>
<volume>16</volume>
<issue>4</issue>
<fpage>444</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.06.008</pub-id>
<pub-id pub-id-type="pmid">20603222</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Summanen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Downes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Komoriya</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Detection of <italic>Clostridium perfringens</italic> toxin genes in the gut microbiota of autistic children</article-title>
<source/>Anaerobe
          <year>2017</year>
<volume>45</volume>
<fpage>133</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2017.02.008</pub-id>
<pub-id pub-id-type="pmid">28215985</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gondalia</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Palombo</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Faecal microbiota of individuals with autism spectrum disorder</article-title>
<source/>E-J Appl Psychol Clin Soc Issues
          <year>2010</year>
<volume>6</volume>
<issue>2</issue>
<fpage>24</fpage>
<lpage>29</lpage>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gondalia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Palombo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings</article-title>
<source/>Autism Res
          <year>2012</year>
<volume>5</volume>
<issue>6</issue>
<fpage>419</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1253</pub-id>
<pub-id pub-id-type="pmid">22997101</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sakaue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sawai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sawai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ozeki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romero-Pérez</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders</article-title>
<source/>Biosci Biotechnol Biochem
          <year>2016</year>
<volume>80</volume>
<issue>12</issue>
<fpage>2450</fpage>
<lpage>2458</lpage>
<pub-id pub-id-type="doi">10.1080/09168451.2016.1222267</pub-id>
<pub-id pub-id-type="pmid">27581276</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iovene</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bombace</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maresca</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sapone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iardino</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Picardi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders</article-title>
<source/>Mycopathologia
          <year>2017</year>
<volume>182</volume>
<issue>3–4</issue>
<fpage>349</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-016-0068-6</pub-id>
<pub-id pub-id-type="pmid">27655151</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wallstrom</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Labaer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>7</issue>
<fpage>e68322-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0068322</pub-id>
<pub-id pub-id-type="pmid">23844187</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Borody</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chittick</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
<fpage>10</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-016-0225-7</pub-id>
<pub-id pub-id-type="pmid">28122648</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Isern</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hoyt</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Howsmon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders</article-title>
<source/>Anaerobe
          <year>2018</year>
<volume>49</volume>
<fpage>121</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2017.12.007</pub-id>
<pub-id pub-id-type="pmid">29274915</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Analysis of the duodenal microbiome in autistic individuals: association with carbohydrate digestion</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2017</year>
<volume>64</volume>
<issue>5</issue>
<fpage>e110</fpage>
<lpage>e116</lpage>
<pub-id pub-id-type="doi">10.1097/MPG.0000000000001458</pub-id>
<pub-id pub-id-type="pmid">27811623</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders-a pilot study</article-title>
<source/>BMC Microbiol
          <year>2017</year>
<volume>17</volume>
<issue>1</issue>
<fpage>204</fpage>
<pub-id pub-id-type="doi">10.1186/s12866-017-1096-1</pub-id>
<pub-id pub-id-type="pmid">28938872</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luna</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Oezguen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Balderas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Venkatachalam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Runge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder</article-title>
<source/>Cell Mol Gastroenterol Hepatol
          <year>2017</year>
<volume>3</volume>
<issue>2</issue>
<fpage>218</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcmgh.2016.11.008</pub-id>
<pub-id pub-id-type="pmid">28275689</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parracho</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McCartney</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children</article-title>
<source/>J Med Microbiol
          <year>2005</year>
<volume>54</volume>
<issue>Pt 10</issue>
<fpage>987</fpage>
<lpage>991</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.46101-0</pub-id>
<pub-id pub-id-type="pmid">16157555</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parracho</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Knott</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bosscher</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McCartney</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders</article-title>
<source/>Int J Probiot Prebiot
          <year>2010</year>
<volume>5</volume>
<issue>2</issue>
<fpage>69</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaaban</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>El Gendy</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Mehanna</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>El-Senousy</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>El-Feki</surname>
<given-names>HSA</given-names>
</name>
<name>
<surname>Saad</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of probiotics in children with autism spectrum disorder: a prospective, open-label study</article-title>
<source/>Nutr Neurosci
          <year>2018</year>
<volume>21</volume>
<issue>9</issue>
<fpage>676</fpage>
<lpage>681</lpage>
<pub-id pub-id-type="doi">10.1080/1028415X.2017.1347746</pub-id>
<pub-id pub-id-type="pmid">28686541</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Son</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rowehl</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the simons simplex collection</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<issue>10</issue>
<fpage>e0137725-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0137725</pub-id>
<pub-id pub-id-type="pmid">26427004</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Finegold</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Real-time PCR quantitation of clostridia in feces of autistic children</article-title>
<source/>Appl Environ Microbiol
          <year>2004</year>
<volume>70</volume>
<issue>11</issue>
<fpage>6459</fpage>
<lpage>6465</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.70.11.6459-6465.2004</pub-id>
<pub-id pub-id-type="pmid">15528506</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New evidences on the altered gut microbiota in autism spectrum disorders</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>1</volume>
<issue>5</issue>
<fpage>1</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Husarova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lakatosova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bakos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vlkova</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Babinska</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal microbiota in children with autism in Slovakia</article-title>
<source/>Physiol Behav
          <year>2015</year>
<volume>138</volume>
<fpage>179</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2014.10.033</pub-id>
<pub-id pub-id-type="pmid">25446201</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christophersen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sorich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Angley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Low relative abundances of the mucolytic bacterium <italic>Akkermansia muciniphila</italic> and <italic>Bifidobacterium</italic> spp. in feces of children with autism</article-title>
<source/>Appl Environ Microbiol
          <year>2011</year>
<volume>77</volume>
<issue>18</issue>
<fpage>6718</fpage>
<lpage>6721</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.05212-11</pub-id>
<pub-id pub-id-type="pmid">21784919</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christophersen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sorich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Angley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Increased abundance of <italic>Sutterella</italic> spp. and <italic>Ruminococcus torques</italic> in feces of children with autism spectrum disorder</article-title>
<source/>Mol Autism
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-42</pub-id>
<pub-id pub-id-type="pmid">24188502</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hornig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<issue>9</issue>
<fpage>e24585-e</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0024585</pub-id>
<pub-id pub-id-type="pmid">21949732</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Hornig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parekh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lipkin</surname>
<given-names>WI</given-names>
</name>
</person-group>
<article-title>Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances</article-title>
<source/>MBio
          <year>2012</year>
<volume>3</volume>
<issue>1</issue>
<fpage>e00261-11</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.00261-11</pub-id>
<pub-id pub-id-type="pmid">22233678</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Whon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Proteobacteria: microbial signature of dysbiosis in gut microbiota</article-title>
<source/>Trends Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>9</issue>
<fpage>496</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibtech.2015.06.011</pub-id>
<pub-id pub-id-type="pmid">26210164</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fung</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Interactions between the microbiota, immune and nervous systems in health and disease</article-title>
<source/>Nat Neurosci
          <year>2017</year>
<volume>20</volume>
<issue>2</issue>
<fpage>145</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4476</pub-id>
<pub-id pub-id-type="pmid">28092661</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Sadelhoff</surname>
<given-names>JHJ</given-names>
</name>
<name>
<surname>Perez Pardo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garssen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Bergenhenegouwen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hogenkamp</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Gut-Immune-Brain Axis in autism spectrum disorders; a focus on amino acids</article-title>
<source/>Front Endocrinol
          <year>2019</year>
<volume>10</volume>
<fpage>247</fpage>
<pub-id pub-id-type="doi">10.3389/fendo.2019.00247</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>FV</given-names>
</name>
<name>
<surname>Kovatcheva-Datchary</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vinera</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zitoun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Duchampt</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits</article-title>
<source/>Cell
          <year>2014</year>
<volume>156</volume>
<issue>1–2</issue>
<fpage>84</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">24412651</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parashar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Udayabanu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Gut microbiota regulates key modulators of social behavior</article-title>
<source/>Eur Neuropsychopharmacol
          <year>2016</year>
<volume>26</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2015.11.002</pub-id>
<pub-id pub-id-type="pmid">26613639</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pulikkan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mazumder</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Role of the Gut microbiome in autism spectrum disorders</article-title>
<source/>Adv Exp Med Biol
          <year>2019</year>
<volume>1118</volume>
<fpage>253</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1007/978-3-030-05542-4_13</pub-id>
<pub-id pub-id-type="pmid">30747427</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srikantha</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mohajeri</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>The possible role of the microbiota-gut-brain-axis in autism spectrum disorder</article-title>
<source/>Int J Mol Sci
          <year>2019</year>
<volume>20</volume>
<issue>9</issue>
<fpage>2115</fpage>
<pub-id pub-id-type="doi">10.3390/ijms20092115</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazzoli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pessione</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The neuro-endocrinological role of microbial glutamate and GABA signaling</article-title>
<source/>Front Microbiol
          <year>2016</year>
<volume>7</volume>
<fpage>1934</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.01934</pub-id>
<pub-id pub-id-type="pmid">27965654</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ong</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McIlwain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sawin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schoen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adluru</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome populations are associated with structure-specific changes in white matter architecture</article-title>
<source/>Transl Psychiatry
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-017-0022-5</pub-id>
<pub-id pub-id-type="pmid">29317592</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Maternal immune activation: implicatiosns for neuropsychiatric disorders</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<issue>6301</issue>
<fpage>772</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1126/science.aag3194</pub-id>
<pub-id pub-id-type="pmid">27540164</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring</article-title>
<source/>Science
          <year>2016</year>
<volume>351</volume>
<issue>6276</issue>
<fpage>933</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="doi">10.1126/science.aad0314</pub-id>
<pub-id pub-id-type="pmid">26822608</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Julio-Pieper</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kunze</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Communication between gastrointestinal bacteria and the nervous system</article-title>
<source/>Curr Opin Pharmacol
          <year>2012</year>
<volume>12</volume>
<issue>6</issue>
<fpage>667</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1016/j.coph.2012.09.010</pub-id>
<pub-id pub-id-type="pmid">23041079</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Burgos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mistry</surname>
<given-names>B</given-names>
</name>
<name>
<surname>McVey</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Psychoactive bacteria <italic>Lactobacillus rhamnosus</italic> (JB-1) elicits rapid frequency facilitation in vagal afferents</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2013</year>
<volume>304</volume>
<issue>2</issue>
<fpage>G211</fpage>
<lpage>G220</lpage>
<pub-id pub-id-type="doi">10.1152/ajpgi.00128.2012</pub-id>
<pub-id pub-id-type="pmid">23139216</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Nankova</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bennuri</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>MacFabe</surname>
<given-names>DF</given-names>
</name>
</person-group>
<article-title>Modulation of immunological pathways in autistic and neurotypical lymphoblastoid cell lines by the enteric microbiome metabolite propionic acid</article-title>
<source/>Front Immunol.
          <year>2017</year>
<volume>8</volume>
<fpage>1670</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2017.01670</pub-id>
<pub-id pub-id-type="pmid">29312285</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chacko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wynne</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bennuri</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Slattery</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines</article-title>
<source/>Transl Psychiatry
          <year>2016</year>
<volume>6</volume>
<issue>10</issue>
<fpage>e927</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.189</pub-id>
<pub-id pub-id-type="pmid">27779624</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bennuri</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Wynne</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Slattery</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tippett</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism</article-title>
<source/>Transl Psychiatry
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-017-0089-z</pub-id>
<pub-id pub-id-type="pmid">29391397</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rose</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bennuri</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: a blinded case–control study</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<issue>10</issue>
<fpage>e0186377</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0186377</pub-id>
<pub-id pub-id-type="pmid">29028817</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erny</surname>
<given-names>D</given-names>
</name>
<name>
<surname>de Angelis</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Jaitin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wieghofer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Staszewski</surname>
<given-names>O</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<issue>7</issue>
<fpage>965</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4030</pub-id>
<pub-id pub-id-type="pmid">26030851</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nøhr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Egerod</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Christiansen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gille</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Offermanns</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia</article-title>
<source/>Neuroscience
          <year>2015</year>
<volume>290</volume>
<fpage>126</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.01.040</pub-id>
<pub-id pub-id-type="pmid">25637492</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geva-Zatorsky</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sefik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kua</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pasman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ortiz-Lopez</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mining the human gut microbiota for immunomodulatory organisms</article-title>
<source/>Cell
          <year>2017</year>
<volume>168</volume>
<issue>5</issue>
<fpage>928</fpage>
<lpage>943.e11</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.01.022</pub-id>
<pub-id pub-id-type="pmid">28215708</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Maternal infection and immune involvement in autism</article-title>
<source/>Trends Mol Med
          <year>2011</year>
<volume>17</volume>
<issue>7</issue>
<fpage>389</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.001</pub-id>
<pub-id pub-id-type="pmid">21482187</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atladóttir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thorsen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Deleuran</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of family history of autoimmune diseases and autism spectrum disorders</article-title>
<source/>Pediatrics
          <year>2009</year>
<volume>124</volume>
<issue>2</issue>
<fpage>687</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2008-2445</pub-id>
<pub-id pub-id-type="pmid">19581261</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Ashwood P, Wills S, de Water Van J</collab>
</person-group>
<article-title>The immune response in autism: a new frontier for autism research</article-title>
<source/>J Leukoc Biol
          <year>2006</year>
<volume>80</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.1205707</pub-id>
<pub-id pub-id-type="pmid">16698940</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Legge</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2010</year>
<volume>107</volume>
<issue>44</issue>
<fpage>18933</fpage>
<lpage>18938</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1007028107</pub-id>
<pub-id pub-id-type="pmid">20937875</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Davenport</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The relationship between the human genome and microbiome comes into view</article-title>
<source/>Annu Rev Genet
          <year>2017</year>
<volume>51</volume>
<fpage>413</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-genet-110711-155532</pub-id>
<pub-id pub-id-type="pmid">28934590</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knights</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Silverberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weersma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dijkstra</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complex host genetics influence the microbiome in inflammatory bowel disease</article-title>
<source/>Genome Med.
          <year>2014</year>
<volume>6</volume>
<issue>12</issue>
<fpage>107</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-014-0107-1</pub-id>
<pub-id pub-id-type="pmid">25587358</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poole</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sutter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koren</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Blekhman</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human genetics shape the gut microbiome</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<issue>4</issue>
<fpage>789</fpage>
<lpage>799</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.09.053</pub-id>
<pub-id pub-id-type="pmid">25417156</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tolonen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Human genetic variation and the gut microbiome in disease</article-title>
<source/>Nat Rev Genet
          <year>2017</year>
<volume>18</volume>
<issue>11</issue>
<fpage>690</fpage>
<lpage>699</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2017.63</pub-id>
<pub-id pub-id-type="pmid">28824167</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabouy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Getselter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ziv</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Karpuj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tabouy</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lukic</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders</article-title>
<source/>Brain Behav Immun
          <year>2018</year>
<volume>73</volume>
<fpage>310</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2018.05.015</pub-id>
<pub-id pub-id-type="pmid">29787855</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Keating</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Licinio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wesselingh</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>6</issue>
<fpage>738</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.50</pub-id>
<pub-id pub-id-type="pmid">27090305</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice</article-title>
<source/>J Physiol
          <year>2004</year>
<volume>558</volume>
<issue>Pt 1</issue>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heijtz</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bjorkholm</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proc Natl Acad Sci.
          <year>2011</year>
<volume>108</volume>
<issue>7</issue>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neufeld</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Effects of intestinal microbiota on anxiety-like behavior</article-title>
<source/>Commun Integr Biol
          <year>2011</year>
<volume>4</volume>
<issue>4</issue>
<fpage>492</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.4161/cib.15702</pub-id>
<pub-id pub-id-type="pmid">21966581</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaspar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cases</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Maroteaux</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The developmental role of serotonin: news from mouse molecular genetics</article-title>
<source/>Nat Rev Neurosci
          <year>2003</year>
<volume>4</volume>
<issue>12</issue>
<fpage>1002</fpage>
<lpage>1012</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1256</pub-id>
<pub-id pub-id-type="pmid">14618156</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Côté</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fligny</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bayard</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gershon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mallet</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal serotonin is crucial for murine embryonic development</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2007</year>
<volume>104</volume>
<issue>1</issue>
<fpage>329</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0606722104</pub-id>
<pub-id pub-id-type="pmid">17182745</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McPartland</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reichow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Volkmar</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>2012</year>
<volume>51</volume>
<issue>4</issue>
<fpage>368</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2012.01.007</pub-id>
<pub-id pub-id-type="pmid">22449643</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>